QQQ   310.97 (+2.43%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.00 (-0.18%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   310.97 (+2.43%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.00 (-0.18%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   310.97 (+2.43%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.00 (-0.18%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   310.97 (+2.43%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.00 (-0.18%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
NASDAQ:BWAY

BrainsWay - BWAY Price Target & Analyst Ratings

$2.00
-0.03 (-1.48%)
(As of 02/7/2023 04:18 PM ET)
Add
Compare
Today's Range
$1.98
$2.01
50-Day Range
$1.73
$2.47
52-Week Range
$1.64
$9.18
Volume
38,433 shs
Average Volume
79,653 shs
Market Capitalization
$33.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.19

BrainsWay Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$9.19
359.38% Upside
High Prediction$15.00
Average Prediction$9.19
Low Prediction$3.75
TypeCurrent
2/7/22 to 2/7/23
1 Month Ago
1/8/22 to 1/8/23
3 Months Ago
11/9/21 to 11/9/22
1 Year Ago
2/7/21 to 2/7/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$9.19$9.19$14.00$14.80
Predicted Upside359.38% Upside170.02% Upside109.58% Upside67.91% Upside
Get BrainsWay Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.

BWAY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BWAY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

BrainsWay Stock vs. The Competition

TypeBrainsWayMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.64
2.46
Consensus RatingBuyBuyHold
Predicted Upside353.14% Upside2,505.32% Upside9.44% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/1/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$13.00+546.76%
11/21/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$8.00 ➝ $3.75+96.33%
11/17/2022Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$15.00 ➝ $5.00+128.31%
3/3/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$15.00+94.05%
11/17/2021LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jeffrey Cohen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$16.00 ➝ $17.00+102.38%
5/21/2021Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$15.00+58.39%
8/14/2020Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Mikson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$13.00+96.67%
(Data available from 2/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BWAY Price Target - Frequently Asked Questions

What is BrainsWay's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for BrainsWay stock is Buy based on the current 4 buy ratings for BWAY. The average twelve-month price prediction for BrainsWay is $9.19 with a high price target of $15.00 and a low price target of $3.75. Learn more on BWAY's analyst rating history.

Do Wall Street analysts like BrainsWay more than its competitors?

Analysts like BrainsWay more than other Medical companies. The consensus rating score for BrainsWay is 3.00 while the average consensus rating score for medical companies is 2.64. Learn more on how BWAY compares to other companies.

Does BrainsWay's stock price have much upside?

According to analysts, BrainsWay's stock has a predicted upside of 165.53% based on their 12-month price targets.

What analysts cover BrainsWay?

BrainsWay has been rated by HC Wainwright, Northland Securities, and Raymond James in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:BWAY) was last updated on 2/7/2023 by MarketBeat.com Staff